Interactions between tumor-derived proteins and Toll-like receptors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interactions between tumor-derived proteins and Toll-like receptors
Authors
Keywords
-
Journal
EXPERIMENTAL AND MOLECULAR MEDICINE
Volume 52, Issue 12, Pages 1926-1935
Publisher
Springer Science and Business Media LLC
Online
2020-12-09
DOI
10.1038/s12276-020-00540-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis
- (2019) Keon-Il Im et al. Mucosal Immunology
- A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
- (2019) Hyun Jin Park et al. Journal for ImmunoTherapy of Cancer
- Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion
- (2019) Eman A. Taha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Depression and sterile inflammation: Essential role of danger associated molecular patterns
- (2018) Tina C. Franklin et al. BRAIN BEHAVIOR AND IMMUNITY
- DAMP-TLR-cytokine axis dictates the fate of tumor
- (2018) Ashok Patidar et al. CYTOKINE
- Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis
- (2018) Xuelian Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer
- (2018) Charlotte Thålin et al. PLoS One
- Danger-Associated Molecular Patterns (DAMPs): the Derivatives and Triggers of Inflammation
- (2018) Seema Patel CURRENT ALLERGY AND ASTHMA REPORTS
- A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells
- (2018) Young Seob Kim et al. OncoImmunology
- Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
- (2017) Marion Dajon et al. IMMUNOBIOLOGY
- Api5 a new cofactor of estrogen receptor alpha involved in breast cancer outcome
- (2017) Céline Basset et al. Oncotarget
- Circulating Extracellular Histones Are Clinically Relevant Mediators of Multiple Organ Injury
- (2016) Chihiro Kawai et al. AMERICAN JOURNAL OF PATHOLOGY
- The expression of DAMP proteins HSP70 and cancer-testis antigen SPAG9 in peripheral blood of patients with HCC and lung cancer
- (2016) Biqiong Ren et al. CELL STRESS & CHAPERONES
- HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients
- (2016) A. Napolitano et al. CLINICAL CANCER RESEARCH
- Key Role of DAMP in Inflammation, Cancer, and Tissue Repair
- (2016) Franco Pandolfi et al. CLINICAL THERAPEUTICS
- Damage-associated molecular patterns in cancer: a double-edged sword
- (2016) C Hernandez et al. ONCOGENE
- Sequential domain assembly of ribosomal protein S3 drives 40S subunit maturation
- (2016) Valentin Mitterer et al. Nature Communications
- Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer
- (2016) Jinhoi Song et al. Oncotarget
- Ribosomal protein S3 (rpS3) secreted from various cancer cells is N-linked glycosylated
- (2016) YongJoong Kim et al. Oncotarget
- DAMPs as mediators of sterile inflammation in aging-related pathologies
- (2015) Noa Feldman et al. AGEING RESEARCH REVIEWS
- Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9
- (2015) Yao Liu et al. JOURNAL OF HEPATOLOGY
- Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data
- (2015) Anne J Breugom et al. LANCET ONCOLOGY
- Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
- (2015) Tae Heung Kang et al. Oncotarget
- Endogenous Damage-Associated Molecular Pattern Molecules at the Crossroads of Inflammation and Cancer
- (2015) Geetha Srikrishna et al. NEOPLASIA
- Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner
- (2014) L. Volk-Draper et al. CANCER RESEARCH
- HMGB1 Enhances Immune Suppression by Facilitating the Differentiation and Suppressive Activity of Myeloid-Derived Suppressor Cells
- (2014) K. H. Parker et al. CANCER RESEARCH
- Role of Toll-like receptors in cervical, endometrial and ovarian cancers: A review
- (2014) Nader Husseinzadeh et al. GYNECOLOGIC ONCOLOGY
- The Measure of DAMPs and a role for S100A8 in recruiting suppressor cells in breast cancer lung metastasis
- (2014) Christine N. Vrakas et al. IMMUNOLOGICAL INVESTIGATIONS
- The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
- (2014) Peter Huebener et al. JOURNAL OF CLINICAL INVESTIGATION
- Extracellular histones in tissue injury and inflammation
- (2014) Ramanjaneyulu Allam et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Release and activity of histone in diseases
- (2014) R Chen et al. Cell Death & Disease
- Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
- (2014) Maria Muccioli et al. Frontiers in Immunology
- Cytoplasmic ribosomal protein S3 (rpS3) plays a pivotal role in mitochondrial DNA damage surveillance
- (2013) YongJoong Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Eukaryotic ribosomal protein S3: A constituent of translational machinery and an extraribosomal player in various cellular processes
- (2013) Dmitri Graifer et al. BIOCHIMIE
- Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties
- (2013) Ingrid J. Bettum et al. CANCER LETTERS
- Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice
- (2013) Tobias Pusterla et al. HEPATOLOGY
- Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
- (2013) Agnieszka Kaczmarek et al. IMMUNITY
- p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes
- (2013) Albert R. Davalos et al. JOURNAL OF CELL BIOLOGY
- Api5 Contributes to E2F1 Control of the G1/S Cell Cycle Phase Transition
- (2013) Marina Garcia-Jove Navarro et al. PLoS One
- Tissue Damage-Associated "Danger Signals" Influence T-cell Responses That Promote the Progression of Preneoplasia to Cancer
- (2012) Y. He et al. CANCER RESEARCH
- Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
- (2012) S. Jube et al. CANCER RESEARCH
- TLR signaling in B-cell development and activation
- (2012) Zhaolin Hua et al. Cellular & Molecular Immunology
- Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: A multi-institutional case–control study
- (2012) Matthias Zimmermann et al. CLINICA CHIMICA ACTA
- High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy
- (2012) Yi Luo et al. EUROPEAN JOURNAL OF CANCER
- High-mobility group box 1 (HMGB1)-toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophages
- (2012) Xuefu Wang et al. HEPATOLOGY
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- Structural Biology of the Toll-Like Receptor Family
- (2011) Jin Young Kang et al. Annual Review of Biochemistry
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- How to improve the immunogenicity of chemotherapy and radiotherapy
- (2011) Yuting Ma et al. CANCER AND METASTASIS REVIEWS
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance
- (2011) Feng-Hua Wu et al. CANCER LETTERS
- The role of TLRs in neutrophil activation
- (2011) Lynne R Prince et al. CURRENT OPINION IN PHARMACOLOGY
- Toll-Like Receptors Participate in Macrophage Activation and Intracellular Control of Leishmania (Viannia) panamensis
- (2011) Carolina Gallego et al. INFECTION AND IMMUNITY
- MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
- (2011) James Finke et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Knockdown of HMGB1 in Tumor Cells Attenuates Their Ability To Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-Dependent Antitumor Immunity
- (2011) Z. Liu et al. JOURNAL OF IMMUNOLOGY
- Dendritic Cells and Damage-Associated Molecular Patterns: Endogenous Danger Signals Linking Innate and Adaptive Immunity
- (2011) Gary Nace et al. Journal of Innate Immunity
- HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration
- (2011) H.-M. Gao et al. JOURNAL OF NEUROSCIENCE
- Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
- (2011) U. Sack et al. JNCI-Journal of the National Cancer Institute
- S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression
- (2011) M. Ichikawa et al. MOLECULAR CANCER RESEARCH
- Serum HSP70
- (2011) Sudhir K. Dutta et al. PANCREAS
- The Structural Biology of Toll-like Receptors
- (2011) Istvan Botos et al. STRUCTURE
- Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation
- (2011) Dmitri V. Krysko et al. TRENDS IN IMMUNOLOGY
- Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women
- (2011) Ayshamgul Hasimu et al. Chinese Journal of Cancer
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- High-Mobility Group Box 1, Oxidative Stress, and Disease
- (2010) Daolin Tang et al. ANTIOXIDANTS & REDOX SIGNALING
- High-mobility group box 1 and cancer
- (2010) Daolin Tang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
- (2010) Gerty Schreibelt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Danger signals in tumor cells: a risk factor for autoimmune disease?
- (2010) Volker Schirrmacher et al. Expert Review of Vaccines
- Adaptive immunity
- (2010) Francisco A. Bonilla et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Secreted Heat Shock Protein 90α Induces Colorectal Cancer Cell Invasion through CD91/LRP-1 and NF-κB-mediated Integrin αVExpression
- (2010) Jinn-Shiun Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endogenous ligands of TLR2 and TLR4: agonists or assistants?
- (2010) Clett Erridge JOURNAL OF LEUKOCYTE BIOLOGY
- The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker
- (2010) Rosaria Cammarota et al. Journal of Translational Medicine
- DAMPening Inflammation by Modulating TLR Signalling
- (2010) A. M. Piccinini et al. MEDIATORS OF INFLAMMATION
- Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation
- (2010) H D Park et al. ONCOGENE
- HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
- (2010) D Tang et al. ONCOGENE
- Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells
- (2009) Wenjie Xie et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Toll-like receptors and innate immunity
- (2009) Himanshu Kumar et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting HMGB1 in inflammation
- (2009) Huan Yang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Toll-like receptor expression in normal ovary and ovarian tumors
- (2009) Mingfu Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pancreatic adenocarcinoma up-regulated factor (PAUF), a novel up-regulated secretory protein in pancreatic ductal adenocarcinoma
- (2009) Sun A. Kim et al. CANCER SCIENCE
- The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
- (2009) R Kang et al. CELL DEATH AND DIFFERENTIATION
- Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity
- (2009) Shomyseh Sanjabi et al. CURRENT OPINION IN PHARMACOLOGY
- The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray
- (2009) Tasneem H. Patwa et al. ELECTROPHORESIS
- Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.
- (2009) Wojciech Naumnik et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- The contribution of direct TLR signaling to T cell responses
- (2009) Adeeb H. Rahman et al. IMMUNOLOGIC RESEARCH
- PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression
- (2009) Y Lee et al. ONCOGENE
- HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
- (2009) James F Curtin et al. PLOS MEDICINE
- Emerging functions of ribosomal proteins in gene-specific transcription and translation
- (2008) Mikael S. Lindström BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Toll-like receptors expressed in tumor cells: targets for therapy
- (2008) Li Yu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma
- (2008) Yoshihisa Fujita et al. CANCER LETTERS
- Helicobacter pylori Augments Growth of Gastric Cancers via the Lipopolysaccharide-Toll-like Receptor 4 Pathway whereas Its Lipopolysaccharide Attenuates Antitumor Activities of Human Mononuclear Cells
- (2008) K. Chochi et al. CLINICAL CANCER RESEARCH
- HMGB1: a two-headed signal regulating tumor progression and immunity
- (2008) Lara Campana et al. CURRENT OPINION IN IMMUNOLOGY
- Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer
- (2008) Sang Hoon Rhee et al. GASTROENTEROLOGY
- Regulation of autoimmune inflammation by pro-inflammatory cytokines
- (2008) E KIM et al. IMMUNOLOGY LETTERS
- Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2–MyD88 signal pathway in dendritic cells and enhances Th2 immune responses
- (2008) De Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- RAGE signaling sustains inflammation and promotes tumor development
- (2008) Christoffer Gebhardt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway
- (2008) S. Ghavami et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors
- (2008) Y. Goto et al. MOLECULAR CANCER THERAPEUTICS
- TLR signaling by tumor and immune cells: a double-edged sword
- (2008) B Huang et al. ONCOGENE
- Adjuvant role for cell death during chemo- and radiotherapy of cancer?
- (2007) Patrizia Rovere-Querini et al. Expert Review of Clinical Immunology
- Increased expression of Toll-like receptor 5 during progression of cervical neoplasia
- (2007) W.Y. KIM et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search